Point of Care Hematology Analyzers Market

Global Point of Care Hematology Analyzers Market Size, Trends & Analysis - Forecasts to 2026 By Product Type (Benchtop, Compact, and Integrated), By Differentiation (3-Part Differentiation, and 5-Part Differentiation), By Application (Pediatric Application, Critical Care Application, Blood Donation Application, and Veterinary Application), By End-User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research & Academic Institutes, and Blood Banks), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on May 9 2024 with the latest and most recent market numbers

Point of Care Hematology Analyzers Market Insights

The global point of care hematology analyzers market is projected to grow at a CAGR value of 12.5% during the forecast period [2021 to 2026]. Point of care portable or handheld hematology analyzers use disposable cartridges with the necessary reagents and collect a patient sample using a drop of blood taken from the patient’s finger. Traditional hematology analyzers use drawn blood samples and do not provide quick results as the point of care-based analyzer does.

The application served by the POC analyzers is the pediatric application, critical care application, blood donation application, and veterinary application. With a simple operation system, and the least training requirements, the industry of diagnostics has witnessed rising demand for POC analyzers. The other factors supporting the growth of the analyzers market are high portability, laboratory-like blood analysis, high accuracy rate, ease of use, and cost-effectiveness.

Point of care analyzers helps physicians to validate a data-driven decision and lead a hassle free treatment program for the patient. Complete blood count test is one of the most common and most preferred tests recommended by physicians to analyze the pre-infection stage of the patients. As per the reports by WHO, the US and Europe together contribute to around 2 billion CBC tests annually, and this number is expected to grow rapidly. Latest POC analyzers work on technologies such as machine vision, microfluidics, and artificial intelligence (AI).

Hence, the market for point of care hematology analyzers will be growing rapidly owing to factors such as the increasing number of cases associated with COVID-19, cancer, blood disorders, common infections, anemia, etc., rising geriatric patient pool especially in developing regions, increasing number of blood donation activities, the rising launch of advanced point of care technologies that include the use of machine learning and artificial intelligence (AI).

Moreover, the rising support from government organizations in the form of research funds to launch analyzers in third world countries and increasing demand for automated and emergency care based CBC testing is also helping the market attain rapid growth. Some of the most prominent players such as Sight Diagnostics, Drucker Diagnostics, PixCell Medical, and Sysmex Corporation, are ruling the market as they have successfully launched their FDA-approved products.

However, a lack of awareness regarding the advantages of point of care testing in developing countries and the slow adoption of advanced technology will hamper the growth of the market to some extent.

global point of care hematology analyzers market

Point of Care Hematology Analyzers Market: By Product Type

The point of care hematology analyzer products are categorized into benchtop, compact and integrated systems. The integrated systems segment is analyzed to be the fastest growing segment in the market from 2021 to 2026. This is mainly because of the increasing adoption and demand for AI-based and ML-based point of care systems that can render not only CBC results but also help physicians analyze the report. Data sharing and data storage are the other prime factors supporting the growth of this segment.

Point of Care Hematology Analyzers Market: By Application

Pediatric application, critical care application, blood donation application, and veterinary application are the major segments of the point of care (POC) market. The critical care application will be the largest shareholder of the market owing to factors such as increasing demand for fast turnaround testing arrangements in ICU and critical care department and rising patient admission to the emergency department due to the increasing prevalence of infectious diseases.

Point of Care Hematology Analyzers Market: By Differentiation

The market segmented based on differentiation includes 3-part differentiation and 5-part differentiation. The 5-part differentiation segment will be the fastest growing segment with the highest CAGR value from 2021 to 2026. 5-part analyzers offer efficient testing with around 19 parameters clubbed with high-end flagging capabilities for the point of care applications.

Point of Care Hematology Analyzers Market: By End-User

Hospital laboratories, commercial service providers, government reference laboratories, research & academic institutes, and blood banks are the end-users of the market. Hospital laboratories will be the largest consumer of this device/ system owing to high patient admission to ICU and step-down units for chronic diseases. Also, hospital laboratories have high spending power and are open to adopting advanced technologies easily as compared to other end-users.

asia pacific point of care hematology analyzers market

Point of Care Hematology Analyzers Market: By Region

As per the geographical analysis, the point of care (POC) hematology market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

North America (the United States, Canada, and Mexico) will have a dominant share in the market from 2021 to 2026. The high share of this region is mainly due to the presence of key players in the US market, increasing healthcare expenditure, the high adoption rate for point of care management, and increasing awareness regarding 16 parameter point of care testing. However, on the contrary, the Asia Pacific region will grow with the highest CAGR rate in the market. Rising chronic infections, COVID-19 cases, rare and genetic cancer diseases, and autoimmune disorders will impact the market positively.

Point of Care Hematology Analyzers Market Share and Competitor Analysis

Abbott, PixCell Medical, Drucker Diagnostics, PTS Diagnostics, Sysmex Corporation, Sight Diagnostics, BioSystems S.A., Diatron, HORIBA Medical, Norma Instruments Zrt, Hemocue, Westgard, EKF Diagnostics, Sterilab Services, and Radiometer Medical ApS among others are some of the key players in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Point of Care Hematology Analyzers Industry Overview, 2021-2026

2.1.1 Industry Overview

2.1.2 Type Overview

2.1.3 Application Overview

2.1.4 End-User Overview

2.1.5 Differentiation Type Overview

2.1.6 Regional Overview

Chapter 3 Point of Care Hematology Analyzers Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2021-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Advancements in the PoC hematology analyzers and integration of ML and AI for data analysis

3.3.1.2 Rising cases of cancer, infectious disease and other chronic illness

3.3.2 Industry Challenges

3.3.2.1 Lack of adequate infrastructure and automated PoC solutions in developing nations

3.4 Prospective Growth Scenario

3.4.1 Type Growth Scenario

3.4.2 Application Growth Scenario

3.4.3 End-User Growth Scenario

3.4.4 Differentiation Type Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 Differentiation Type Overview

3.11 Market Share Analysis, 2021

3.11.1 Company Positioning Overview, 2021

Chapter 4 Point of Care Hematology Analyzers Market, By Type

4.1 Type Outlook

4.2 Benchtop

4.2.1 Market Size, By Region, 2021-2026 (USD Million)

4.3 Compact

4.3.1 Market Size, By Region, 2021-2026 (USD Million)

4.4 Integrated

4.4.1 Market Size, By Region, 2021-2026 (USD Million)

Chapter 5 Point of Care Hematology Analyzers Market, By End-User

5.1 End-User Outlook

5.2 Hospital Laboratories

5.2.1 Market Size, By Region, 2021-2026 (USD Million)

5.3 Commercial Service Providers

5.3.1 Market Size, By Region, 2021-2026 (USD Million)

5.4 Government Reference Laboratories

5.4.1 Market Size, By Region, 2021-2026 (USD Million)

5.5 Research & Academic Institutes

5.5.1 Market Size, By Region, 2021-2026 (USD Million)

5.6 Blood Banks

5.6.1 Market Size, By Region, 2021-2026 (USD Million)

Chapter 6 Point of Care Hematology Analyzers Market, By Application

6.1 Pediatric Application

6.1.1 Market Size, By Region, 2021-2026 (USD Million)

6.2 Critical Care Application

6.2.1 Market Size, By Region, 2021-2026 (USD Million)

6.3 Blood Donation Application

6.3.1 Market Size, By Region, 2021-2026 (USD Million)

6.4 Veterinary Application

6.4.1 Market Size, By Region, 2021-2026 (USD Million)

Chapter 7 Point of Care Hematology Analyzers Market, By Differentiation Type

7.1 3-Part Differentiation

7.1.1 Market Size, By Region, 2021-2026 (USD Million)

7.2 5-Part Differentiation

7.2.1 Market Size, By Region, 2021-2026 (USD Million)

Chapter 8 Point of Care Hematology Analyzers Market, By Region

8.1 Regional outlook

8.2 North America

8.2.1 Market Size, By Country 2021-2026 (USD Million)

8.2.2 Market Size, By Type, 2021-2026 (USD Million)

8.2.3 Market Size, By Application, 2021-2026 (USD Million)

8.2.4 Market Size, By End-User, 2021-2026 (USD Million)

8.2.5 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.2.6 U.S.

8.2.6.1 Market Size, By Type, 2021-2026 (USD Million)

8.2.4.2 Market Size, By Application, 2021-2026 (USD Million)

8.2.4.3 Market Size, By End-User, 2021-2026 (USD Million)

Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.2.7 Canada

8.2.7.1 Market Size, By Type, 2021-2026 (USD Million)

8.2.7.2 Market Size, By Application, 2021-2026 (USD Million)

8.2.7.3 Market Size, By End-User, 2021-2026 (USD Million)

8.2.7.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.3 Europe

8.3.1 Market Size, By Country 2021-2026 (USD Million)

8.3.2 Market Size, By Type, 2021-2026 (USD Million)

8.3.3 Market Size, By Application, 2021-2026 (USD Million)

8.3.4 Market Size, By End-User, 2021-2026 (USD Million)

8.3.5 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.3.6 Germany

8.3.6.1 Market Size, By Type, 2021-2026 (USD Million)

8.3.6.2 Market Size, By Application, 2021-2026 (USD Million)

8.3.6.3 Market Size, By End-User, 2021-2026 (USD Million)

8.3.6.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.3.7 UK

8.3.7.1 Market Size, By Type, 2021-2026 (USD Million)

8.3.7.2 Market Size, By Application, 2021-2026 (USD Million)

8.3.7.3 Market Size, By End-User, 2021-2026 (USD Million)

8.3.7.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.3.8 France

8.3.8.1 Market Size, By Type, 2021-2026 (USD Million)

8.3.8.2 Market Size, By Application, 2021-2026 (USD Million)

8.3.8.3 Market Size, By End-User, 2021-2026 (USD Million)

8.3.8.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.3.9 Italy

8.3.9.1 Market Size, By Type, 2021-2026 (USD Million)

8.3.9.2 Market Size, By Application, 2021-2026 (USD Million)

8.3.9.3 Market Size, By End-User, 2021-2026 (USD Million)

8.3.9.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.3.10 Spain

8.3.10.1 Market Size, By Type, 2021-2026 (USD Million)

8.3.10.2 Market Size, By Application, 2021-2026 (USD Million)

8.3.10.3 Market Size, By End-User, 2021-2026 (USD Million)

8.3.10.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.3.11 Russia

8.3.11.1 Market Size, By Type, 2021-2026 (USD Million)

8.3.11.2 Market Size, By Application, 2021-2026 (USD Million)

8.3.11.3 Market Size, By End-User, 2021-2026 (USD Million)

8.3.11.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.4 Asia Pacific

8.4.1 Market Size, By Country 2021-2026 (USD Million)

8.4.2 Market Size, By Type, 2021-2026 (USD Million)

8.4.3 Market Size, By Application, 2021-2026 (USD Million)

8.4.4 Market Size, By End-User, 2021-2026 (USD Million)

8.4.5 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.4.6 China

8.4.6.1 Market Size, By Type, 2021-2026 (USD Million)

8.4.6.2 Market Size, By Application, 2021-2026 (USD Million)

8.4.6.3 Market Size, By End-User, 2021-2026 (USD Million)

8.4.6.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.4.7 India

8.4.7.1 Market Size, By Type, 2021-2026 (USD Million)

8.4.7.2 Market Size, By Application, 2021-2026 (USD Million)

8.4.7.3 Market Size, By End-User, 2021-2026 (USD Million)

8.4.7.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.4.8 Japan

8.4.8.1 Market Size, By Type, 2021-2026 (USD Million)

8.4.8.2 Market Size, By Application, 2021-2026 (USD Million)

8.4.8.3 Market Size, By End-User, 2021-2026 (USD Million)

8.4.8.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.4.9 Australia

8.4.9.1 Market Size, By Type, 2021-2026 (USD Million)

8.4.9.2 Market size, By Application, 2021-2026 (USD Million)

8.4.9.3 Market Size, By End-User, 2021-2026 (USD Million)

8.4.9.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.4.10 South Korea

8.4.10.1 Market Size, By Type, 2021-2026 (USD Million)

8.4.10.2 Market Size, By Application, 2021-2026 (USD Million)

8.4.10.3 Market Size, By End-User, 2021-2026 (USD Million)

8.4.10.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.5 Latin America

8.5.1 Market Size, By Country 2021-2026 (USD Million)

8.5.2 Market Size, By Type, 2021-2026 (USD Million)

8.5.3 Market Size, By Application, 2021-2026 (USD Million)

8.5.4 Market Size, By End-User, 2021-2026 (USD Million)

8.5.5 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.5.6 Brazil

8.5.6.1 Market Size, By Type, 2021-2026 (USD Million)

8.5.6.2 Market Size, By Application, 2021-2026 (USD Million)

8.5.6.3 Market Size, By End-User, 2021-2026 (USD Million)

8.5.6.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.5.7 Mexico

8.5.7.1 Market Size, By Type, 2021-2026 (USD Million)

8.5.7.2 Market Size, By Application, 2021-2026 (USD Million)

8.5.7.3 Market Size, By End-User, 2021-2026 (USD Million)

8.5.7.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.5.8 Argentina

8.5.8.1 Market Size, By Type, 2021-2026 (USD Million)

8.5.8.2 Market Size, By Application, 2021-2026 (USD Million)

8.5.8.3 Market Size, By End-User, 2021-2026 (USD Million)

8.5.8.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.6 MEA

8.6.1 Market Size, By Country 2021-2026 (USD Million)

8.6.2 Market Size, By Type, 2021-2026 (USD Million)

8.6.3 Market Size, By Application, 2021-2026 (USD Million)

8.6.4 Market Size, By End-User, 2021-2026 (USD Million)

8.6.5 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.6.6 Saudi Arabia

8.6.6.1 Market Size, By Type, 2021-2026 (USD Million)

8.6.6.2 Market Size, By Application, 2021-2026 (USD Million)

8.6.6.3 Market Size, By End-User, 2021-2026 (USD Million)

8.6.6.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.6.7 UAE

8.6.7.1 Market Size, By Type, 2021-2026 (USD Million)

8.6.7.2 Market Size, By Application, 2021-2026 (USD Million)

8.6.7.3 Market Size, By End-User, 2021-2026 (USD Million)

8.6.7.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

8.6.8 South Africa

8.6.8.1 Market Size, By Type, 2021-2026 (USD Million)

8.6.8.2 Market Size, By Application, 2021-2026 (USD Million)

8.6.8.3 Market Size, By End-User, 2021-2026 (USD Million)

8.6.8.4 Market Size, By Differentiation Type, 2021-2026 (USD Million)

Chapter 9 Company Landscape

9.1 Competitive Analysis, 2021

9.2 Abbott

9.2.1 Company Overview

9.2.2 Financial Analysis

9.2.3 Strategic Positioning

9.2.4 Info Graphic Analysis

9.3 PixCell Medical

9.3.1 Company Overview

9.3.2 Financial Analysis

9.3.3 Strategic Positioning

9.3.4 Info Graphic Analysis

9.4 Drucker Diagnostics

9.4.1 Company Overview

9.4.2 Financial Analysis

9.4.3 Strategic Positioning

9.4.4 Info Graphic Analysis

9.5 PTS Diagnostics

9.5.1 Company Overview

9.5.2 Financial Analysis

9.5.3 Strategic Positioning

9.5.4 Info Graphic Analysis

9.6 Sysmex Corporation

9.6.1 Company Overview

9.6.2 Financial Analysis

9.6.3 Strategic Positioning

9.6.4 Info Graphic Analysis

9.7 Sight Diagnostics

9.7.1 Company Overview

9.7.2 Financial Analysis

9.7.3 Strategic Positioning

9.7.4 Info Graphic Analysis

9.8 BioSystems S.A.

9.8.1 Company Overview

9.8.2 Financial Analysis

9.8.3 Strategic Positioning

9.8.4 Info Graphic Analysis

9.9 Diatron

9.9.1 Company Overview

9.9.2 Financial Analysis

9.9.3 Strategic Positioning

9.9.4 Info Graphic Analysis

9.10 HORIBA Medical

9.10.1 Company Overview

9.10.2 Financial Analysis

9.10.3 Strategic Positioning

9.10.4 Info Graphic Analysis

9.11 Other Companies

9.11.1 Company Overview

9.11.2 Financial Analysis

9.11.3 Strategic Positioning

9.11.4 Info Graphic Analysis

The Global Point of Care Hematology Analyzers Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Point of Care Hematology Analyzers Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global point of care hematology analyzers market?

The global point of care hematology analyzers market size is projected to grow at a CAGR of 12.5% during the forecast period.

Who are the major vendors in the point of care hematology analyzers market?

Key and innovative vendors in the point of care hematology analyzers market include Abbott, PixCell Medical, Drucker Diagnostics, PTS Diagnostics, Sysmex Corporation, Sight Diagnostics, BioSystems S.A., Diatron, HORIBA Medical, Norma Instruments Zrt, Hemocue, Westgard, EKF Diagnostics, Sterilab Services, and Radiometer Medical ApS.

Which region has the highest market share in the point of care hematology analyzers market?

North America is estimated to hold the highest market share in the point of care hematology analyzers market.

What is the Covid-19 impact on future point of care hematology analyzers manufacturers?

Globally, Covid-19 impact on the future point of care hematology analyzers market will be quite significant for the manufacturers. North America would be leading because of the increasing healthcare expenditure. Subsequently, the Asia Pacific market will be growing the fastest because of the rising prevalence of chronic infections and COVID-19 cases.

What are the major drivers in the point of care hematology analyzers market?

The major driving factors for the point of care hematology analyzers market include the increasing number of cases associated with COVID-19, cancer, blood disorders, common infections, anemia, etc.; rising geriatric patient pool especially in developing regions; an increasing number of blood donation activities; the rising launch of advanced point of care technologies that include the use of machine learning and artificial intelligence (AI); the rising support from government organizations in the form of research funds to launch analyzers; increasing demand for automated and emergency care based CBC.